Clinical Trial Update: Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib

View source ↗

Summary

A completed clinical trial evaluating biomarker profiles in Asia Pacific HER2-positive breast cancer patients treated with lapatinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Metastasis | Status: COMPLETED